Aaron J. Storey

High Impact

Researcher

UAMS

Last publication 2026 Last refreshed 2026-05-23

faculty

23 h-index 135 pubs 1,976 cited

Research Areas

Links

ORCID Lab Website

OverviewAI-generated summary

Aaron J. Storey's research investigates molecular mechanisms underlying disease, with a focus on cancer and kidney diseases. His work has explored the role of epigenetic modifications and chromatin dynamics in cancer development, including the impact of phase separation on aberrant chromatin looping and the suppression of oncogenic nodes by targeted PROTAC degraders. Storey has also identified potential therapeutic targets in primary membranous nephropathy, a kidney disease, through proteomic analysis and mass spectrometry.

His publication record includes studies on the function of specific proteins like TNRC18 in regulating endogenous retrotransposons and the identification of novel antigens in membranous nephropathy. Storey's research network includes numerous collaborations with colleagues at the University of Arkansas for Medical Sciences, such as Samuel G. Mackintosh, Alan J. Tackett, Sydnye L. Shuttleworth, and Vijay Patel, with whom he has co-authored multiple publications.

With an h-index of 22 and over 1,800 citations across 133 publications, Storey is recognized as a highly cited researcher. His active laboratory website suggests ongoing research and engagement in the scientific community. His recent activity indicates continued contributions to biomedical research.

Metrics

h-index: 23
Publications: 135
Citations: 1,976

Selected Publications

BAHCC1 binds H4K20me1 to facilitate the MCM complex loading and DNA replication (2025)

1 citation DOI OpenAlex
The phenylalanine-and-glycine repeats of NUP98 oncofusions form condensates that selectively partition transcriptional coactivators (2025)

18 citations DOI OpenAlex
Dynamic global acetylation remodeling during the yeast heat shock response (2025)

1 citation DOI OpenAlex
One-pot method for preparing DNA, RNA, and protein for multiomics analysis (2024)

8 citations DOI OpenAlex
TNRC18 engages H3K9me3 to mediate silencing of endogenous retrotransposons (2023)

58 citations DOI OpenAlex
304 Discovering T cell proteome turnover dynamics to enhance persistence in solid tumors (2023)

DOI OpenAlex
Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma (2023)

13 citations DOI OpenAlex
Characterization of methionine dependence in melanoma cells (2023)

11 citations DOI OpenAlex
Proprotein convertase subtilisin/kexin type 6 (PCSK6) is a likely antigenic target in membranous nephropathy and nonsteroidal anti-inflammatory drug use (2023)

38 citations DOI OpenAlex
Characterization of methionine dependence in melanoma cells (2023)

2 citations DOI OpenAlex
Discovery of seven novel putative antigens in membranous nephropathy and membranous lupus nephritis identified by mass spectrometry (2023)

51 citations DOI OpenAlex
The Alternative Pathway Is Necessary and Sufficient for Complement Activation by Anti-THSD7A Autoantibodies, Which Are Predominantly IgG4 in Membranous Nephropathy (2022)

18 citations DOI OpenAlex
Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeutic (2022)

52 citations DOI OpenAlex
Cubilin and amnionless protein are novel target antigens in anti–brush border antibody disease (2022)

7 citations DOI OpenAlex
DNA-PKcs kinase activity stabilizes the transcription factor Egr1 in activated immune cells (2021)

21 citations DOI OpenAlex